{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T15:55:40Z","timestamp":1726847740960},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Anti-CD20 monoclonal antibody treatment has not only increased survival and cure rates in many non-Hodgkin lymphomas, but also has prompted an explosion in the development of novel antibodies and biologically active substances with specific cellular targets in the field of malignancies treatment. Since the robust immune responses are elicited by the gene-modified T cells, gene based T cell therapy may also provide a powerful tool for cancer immunotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we developed a vector construction encoding a chimeric T cell receptor that recognizes the CD20 antigen and delivers co-stimulatory signals to achieve T cell activation. One non-Hodgkin lymphoma cell line Raji cells co-cultured with peripheral blood-derived T cells were stably transfected with anti-CD20scFvFc\/CD28\/CD3zeta gene or anti-CD20scFvFc gene. T cells expressing anti-CD20scFvFc\/CD28\/CD3zeta or anti-CD20scFvFc gene co-cultured with CD20 positive Raji cells for different times. Cell lysis assay was carried by [<jats:sup>3<\/jats:sup>H]TdR release assay. The expressions of Fas, Bcl-2 and Caspase-3 of Raji cells were detected by flow cytometric. The secretion of IFN-gamma and IL-2 in co-culture medium was tested by ELISA assay. Activity of AP-1 was analyzed by EMSA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Following efficient transduction of peripheral blood-derived T cells with anti-CD20scFvFc\/CD28\/CD3zeta gene, an obvious cell lysis of Raji cells was observed in co-culture. T cells transduced anti-CD20scFvFc\/CD28\/CD3zeta gene had superior secretion of IFN-gamma and IL-2 compared to T cells transduced anti-CD20scFvFc gene. Also it led to a much stronger Fas-induced apoptosis signaling transduction in target cancer cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>So adoptively T cells transduced anti-CD20scFvFc\/CD28\/CD3zeta gene mediates enhanced anti-tumor activities against CD20 positive tumor cells, suggesting a potential of gene-based immunotherapy for non-Hodgkin lymphoma.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1756-9966-29-121","type":"journal-article","created":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T19:49:36Z","timestamp":1283543376000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potential therapeutic strategy for non-Hodgkin lymphoma by anti-CD20scFvFc\/CD28\/CD3zeta gene tranfected T cells"],"prefix":"10.1186","volume":"29","author":[{"given":"Yihu","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panpan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,3]]},"reference":[{"issue":"6","key":"368_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1517\/14656560902895715","volume":"10","author":"M Prichard","year":"2009","unstructured":"Prichard M, Harris T, Williams ME, Densmore JJ: Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma. Expert Opin Pharmacother. 2009, 10 (6): 983-995. 10.1517\/14656560902895715.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"368_CR2","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1073\/pnas.90.2.720","volume":"90","author":"Z Eshhar","year":"1993","unstructured":"Eshhar Z, Waks T, Gross G, Schindler DG: Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci USA. 1993, 90 (2): 720-724. 10.1073\/pnas.90.2.720.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"368_CR3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1517\/14712590903260785","volume":"9","author":"BG Till","year":"2009","unstructured":"Till BG, Press OW: Treatment of lymphoma with adoptively transferred T cells. Expert Opin Biol Ther. 2009, 9 (11): 1407-1425. 10.1517\/14712590903260785.","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"368_CR4","first-page":"3904","volume":"6","author":"AT Stopeck","year":"2000","unstructured":"Stopeck AT, Gessner A, Miller TP, Hersh EM, Johnson CS, Cui H, Frutiger Y, Grogan TM: Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma. Clin Cancer Res. 2000, 6 (10): 3904-3909.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"368_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1084\/jem.188.4.619","volume":"188","author":"A Krause","year":"1998","unstructured":"Krause A, Guo HF, Latouche JB, Tan C, Cheung NK, Sadelain M: Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes. J Exp Med. 1998, 188 (4): 619-626. 10.1084\/jem.188.4.619.","journal-title":"J Exp Med"},{"issue":"7","key":"368_CR6","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1080\/10428190802064958","volume":"49","author":"K Yu","year":"2008","unstructured":"Yu K, Hu Y, Tan Y, Shen Z, Jiang S, Qian H, Liang B, Shan D: Immunotherapy of lymphomas with T cells modified by anti-CD20 scFv\/CD28\/CD3zeta recombinant gene. Leuk Lymphoma. 2008, 49 (7): 1368-1373. 10.1080\/10428190802064958.","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"368_CR7","first-page":"251","volume":"67","author":"T Van Meerten","year":"2009","unstructured":"Van Meerten T, Hagenbeek A: CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma. Neth J Med. 2009, 67 (7): 251-259.","journal-title":"Neth J Med"},{"issue":"47","key":"368_CR8","doi-asserted-by":"publisher","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","volume":"22","author":"MR Smith","year":"2003","unstructured":"Smith MR: Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene. 2003, 22 (47): 7359-7368. 10.1038\/sj.onc.1206939.","journal-title":"Oncogene"},{"issue":"22","key":"368_CR9","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, et al: Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008, 359 (22): 2313-2323. 10.1056\/NEJMoa0802885.","journal-title":"N Engl J Med"},{"issue":"11","key":"368_CR10","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1182\/blood-2002-11-3442","volume":"101","author":"N Mounier","year":"2003","unstructured":"Mounier N, Briere J, Gisselbrecht C, Emile JF, Lederlin P, Sebban C, Berger F, Bosly A, Morel P, Tilly H, et al: Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). Blood. 2003, 101 (11): 4279-4284. 10.1182\/blood-2002-11-3442.","journal-title":"Blood"},{"key":"368_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/14653240600620176","volume":"8","author":"LJ Cooper","year":"2006","unstructured":"Cooper LJ, Ausubel L, Gutierrez M, Stephan S, Shakeley R, Olivares S, Serrano LM, Burton L, Jensen MC, Forman SJ, DiGiusto DL: Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma. Cytotherapy. 2006, 8: 105-117. 10.1080\/14653240600620176.","journal-title":"Cytotherapy"},{"key":"368_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/CJI.0b013e3181bed253","volume":"33","author":"J Rosenblatt","year":"2010","unstructured":"Rosenblatt J, Wu Z, Vasir B, Zarwan C, Stone R, Mills H, Friedman T, Konstantinopoulos PA, Spentzos D, Ghebremichael M, et al: Generation of tumor-specific T lymphocytes using dendritic cell\/tumor fusions and anti-CD3\/CD28. J Immunother. 2010, 33: 155-166. 10.1097\/CJI.0b013e3181bed253.","journal-title":"J Immunother"},{"issue":"7","key":"368_CR13","first-page":"2487","volume":"9","author":"L Wall","year":"2003","unstructured":"Wall L, Burke F, Barton C, Smyth J, Balkwill F: IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro. Clin Cancer Res. 2003, 9 (7): 2487-2496.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"368_CR14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4049\/jimmunol.130.2.988","volume":"130","author":"K Handa","year":"1983","unstructured":"Handa K, Suzuki R, Matsui H, Shimizu Y, Kumagai K: Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production. J Immunol. 1983, 130 (2): 988-992.","journal-title":"J Immunol"},{"issue":"4","key":"368_CR15","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.4049\/jimmunol.143.4.1210","volume":"143","author":"E Maraskovsky","year":"1989","unstructured":"Maraskovsky E, Chen WF, Shortman K: IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. J Immunol. 1989, 143 (4): 1210-1214.","journal-title":"J Immunol"},{"issue":"7042","key":"368_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nature03579","volume":"435","author":"T Oltersdorf","year":"2005","unstructured":"Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, et al: An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005, 435 (7042): 677-681. 10.1038\/nature03579.","journal-title":"Nature"},{"issue":"3","key":"368_CR17","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1182\/blood.V99.3.1038","volume":"99","author":"JC Byrd","year":"2002","unstructured":"Byrd JC, Kitada S, Flinn IW, Aron JL, Pearson M, Lucas D, Reed JC: The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood. 2002, 99 (3): 1038-1043. 10.1182\/blood.V99.3.1038.","journal-title":"Blood"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-29-121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T04:47:52Z","timestamp":1685767672000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-29-121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,3]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-29-121","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,3]]},"assertion":[{"value":"3 July 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"121"}}